![]() Opiates other than codeine were at their lowest positivity rate in more than a decade. 0.67%) and hydromorphone positivity declined 22% (0.59% vs. ![]() 0.61%), hydrocodone positivity declined 17% (0.81% vs. More notably, oxycodones (oxycodone and/or oxymorphone) positivity declined 12% between 20 (0.69% vs. workforce in urine drug testing declined 17% between 20 (0.47% versus 0.39%). Quest reported that the positivity rate for opiates in the general U.S. ![]() The one bit of good news is that prescription opiate positivity rates declined dramatically on a national basis. The new data indicates shifting patterns of drug use, with cocaine and amphetamines positivity surging in some areas of the country and marijuana positivity rising sharply in states with newer recreational use statutes. “These changing patterns and geographical variations may challenge the ability of employers to anticipate the ‘drug of choice’ for their workforce or where to best focus their drug prevention efforts to ensure a safe and healthy work environment.” Not only have declines appeared to have bottomed out, but also in some drug classes and areas of the country drug positivity rates are increasing,” Barry Sample, senior director of science and technology at Quest Diagnostics, said in a statement. “It’s unfortunate that we mark 30 years of the Drug-Free Workplace Act with clear evidence that drugs continue to invade the country’s workplaces. The findings were made from analysis of more than 10 million workforce drug test results. workforce in 2017 continued to hold at 4.2%, which is still 0.7% higher than the positivity rate from 2012, which represented a 30-year low. Overall positivity in urine drug testing among the combined U.S. Workforce use of illicit drugs across the board-including cocaine, marijuana and methamphetamine-remains at its highest rate in a decade, a new study by Quest Diagnostics found.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |